Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication (Q33735409)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

0 references

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication (English)

1 reference

Europe PubMed Central

29 July 2017

Helicobacter pylori

0 references

0 references

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

David Y. Graham

3

object named as

David Y Graham

1 reference

Europe PubMed Central

29 July 2017

author name string

Abdallah Said Essa

1

1 reference

Europe PubMed Central

29 July 2017

Jennifer Rosenthal Kramer

2

1 reference

Europe PubMed Central

29 July 2017

Gerhard Treiber

4

1 reference

Europe PubMed Central

29 July 2017

publication date

1 April 2009

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

14

1 reference

Europe PubMed Central

29 July 2017

2

1 reference

Europe PubMed Central

29 July 2017

109-118

1 reference

Europe PubMed Central

29 July 2017

New concepts of resistance in the treatment of Helicobacter pylori infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

Eradication therapy for Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

Measuring inconsistency in meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

The hazards of scoring the quality of clinical trials for meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

Operating characteristics of a rank correlation test for publication bias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

21 June 2018

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2009.00671.X

21 January 2018

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

30 October 2018

Sequential regimens for Helicobacter pylori eradication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

30 October 2018

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

30 October 2018

Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

30 October 2018

Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

30 October 2018

A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

30 October 2018

A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

30 October 2018

The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

30 October 2018

Invited commentary: a critical look at some popular meta-analytic methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

30 October 2018

Can meta-analysis be salvaged?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840655

30 October 2018

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2009.00671.X

21 January 2018

Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication

1 reference

https://pubmed.ncbi.nlm.nih.gov/19298338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new quadruple therapy for the eradication of Helicobacter pylori. Effect of pretreatment with omeprazole on the cure rate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19298338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A report card to grade Helicobacter pylori therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19298338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Four-Day, Twice Daily, Quadruple Therapy with Amoxicillin, Clarithromycin, Tinidazole and Omeprazole to Cure Helicobacter pylori Infection: A Pilot Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19298338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19298338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/19298338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1523-5378.2009.00671.X

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33735409&oldid=1586434166"